United States · Biopharma startup
United States · Foghorn Therapeutics
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Funding reportedLast round: Post ipo equity
What company datasets say Foghorn Therapeutics raised
Funding, as reported
Reported in all$221Min dollars
Rounds3
Last roundPost ipo equity
Last round dateMay 2024
Investors listed4
Biopharma in United States
Startups like it
Altos LabsSan Francisco · founded 2021
VaxcyteSan Carlos · founded 2013
Madrigal PharmaceuticalsConshohocken · founded 2011
Harmony BiosciencesPlymouth Meeting · founded 2017
Kura OncologyLa Jolla · founded 2014
ImmunovantNew York · founded 2018
SolugenHouston · founded 2016
Dianthus TherapeuticsWaltham · founded 2019
Is this your company?
Add your raise, your deck and your story, and put Foghorn Therapeutics in front of investors. Or tell us what we have wrong.